Choosing the right immunoassay platform for cell and gene therapy bioanalysis is crucial due to stringent safety, precision, and regulatory demands. Factors such as high precision, rapid data generation, robustness, and low sample consumption are key. Platforms like Gyrolab® offer automation, flexibility, and biosafety, making them ideal for efficient and accurate bioanalysis in therapy development.

Join for free to read